1. McGill HC Jr, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712–2718PMID : 12057983.
2. Eberly LE, Stamler J, Neaton JD. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med 2003;163:1077–1083PMID : 12742806.
3. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality: The Framingham Heart Study. Arteriosclerosis 1988;8:737–741PMID : 3196218.
4. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32–47PMID : 2293751.
5. Harris T, Cook EF, Kannel W, Schatzkin A, Goldman L. Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension 1985;7:118–124PMID : 3980054.
6. Selvin E, Coresh J, Golden SH, et al. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005;165:1910–1916PMID : 16157837.
7. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709–2716PMID : 12460094.
8. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112:666–673PMID : 16061755.
9. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–689PMID : 11315831.
11. Knutsen R, Knutsen SF, Curb JD, et al. The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol 1988;41:293–302PMID : 3339383.
12. Kannel WB, Anderson K, McGee DL, Degatano LS, Stampfer MJ. Nonspecific electro-cardiographic abnormality as a predictor of coronary heart disease: the Framingham study. Am Heart J 1987;113:370–376PMID : 3812192.
13. Denes P, Larson JC, Lloyd-Jones DM, Degatano LS, Stampfer MJ. Major and minor ECG abnormalities in asymptomatic women and risk of cardio-vascular events and mortality. JAMA 2007;97:978–985PMID : 17341712.
14. Nabipour I, Amiri M, Imami SR, et al. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study. Int J Cardiol 2007;118:48–53PMID : 16875744.
15. Cerniauskiene LR, Reklaitiene R, Luksiene DI, et al. Association of metabolic syndrome with ischemic heart disease among middle-aged Kaunas population. Medicina 2005;41:435–441PMID : 15947528.
16. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association / National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–2752PMID : 16157765.
17. The World Health Organization Western Pacific Region, and the International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. 2000;Melbourne: Health Communications Australia.
18. Rautaharju PM, Park L, Rautaharju FS, Crow R. A standardized procedure for locating and documenting ECG chest electrode positions: consideration of the effect of breast tissue on ECG amplitudes in women. J Electrocardiol 1998;31:17–29PMID : 9533374.
19. Rautaharju PM, Park LP, Chaitman BR, Rautaharju F, Zhang ZM. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol 1998;31:157–187PMID : 9682893.
21. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007;30:8–13PMID : 17192325.
22. Andreadis EA, Tsourous GI, Tzavara CK, et al. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population. Am J Hypertens 2007;20:558–564PMID : 17485022.
23. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245–1250PMID : 15326067.
24. Zhao D, Grundy SM, Wang W, et al. Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged Chinese. Am J Cardiol 2007;100:835–839PMID : 17719329.
25. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005;365:1398–1405PMID : 15836888.
26. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356–359PMID : 11790215.
27. Oh JY, Hong YS, Sung YA, Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 2004;27:2027–2032PMID : 15277435.
28. Kim ES, Han SM, Kim YI, et al. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 2004;21:1141–1143PMID : 15384963.
29. He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006;47:1588–1594PMID : 16630995.
30. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14786 middle-aged men and women in Finland. Circulation 1999;99:1165–1172PMID : 10069784.
31. De Bacquer D, De Backer G, Kornitzer M, et al. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. J Am Coll Cardiol 1998;32:680–685PMID : 9741511.